Email ID
Password
Scrip   
Cephalon profits up, exceeds sales guidance
05 August 2009
Sita Shah

Cephalon posted profits of $84.8 million in the second quarter, up by 63% as a result of robust sales and the addition of Arana Therapeutics. Profits in the first half rose by 74% to $143.3 million.

The company acquired a controlling stake in Arana in May to boost its portfolio of biologics...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36